ArticleCancers2024

Revamping Non-Small Cell Lung Cancer Treatments in Stages II and III: Preparing Healthcare for Cutting-Edge Immuno-Oncology Regimens.

Luca Bertolaccini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.